Feb 22, 2022 . The J&J/Janssen COVID-19 vaccine contains a piece of a modified virus that is not the virus that causes COVID-19. This modified virus is called the vector virus. The vector virus cannot reproduce itself, so it cannot cause COVID-19. This vector virus gives instructions to cells in the body to create an immune response.
Show more
See More
39 rows . a Janssen Pharmaceutical Company of Johnson & Johnson Authorized Use For the …
Show more
See More
Janssen (Johnson & Johnson) COVID-19 vaccine materials have been updated to include the Interim Clinical Considerations for the Use of COVID-19 Vaccines Currently Authorized in the United States from February 22, 2022. Preparation and Administration Information Updates. Updates on 2/22/2022. The following have been updated to reference the ...
Show more
See More
Read this Fact Sheet for information about the Janssen COVID-19 Vaccine. Talk to the vaccination provider if you have questions. It is your choice to receive the Janssen COVID-19 Vaccine. The Janssen COVID-19 Vaccine is administered as a single dose, into the muscle. The Janssen COVID-19 Vaccine may not protect everyone.
Show more
See More
The Janssen COVID‑19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID‑19) in individuals 18 years of age and older. FDA EUA Letter for the Janssen COVID-19 Vaccine
Show more
See More
The Janssen COVID-19 Vaccine is supplied in a carton of 10 multi-dose vials (NDC 59676-580-15). A maximum of 5 doses of 0.5 mL can be withdrawn from the multi-dose vial (NDC 59676-580-05). The vial stoppers are not made with natural rubber latex. Storage, Dosage and Administration Guide LOGISTICS FLASH CARD Storage and Handling*
Show more
See More
)$&76+((7)255(&,3,(176 $1'&$5(*,9(56 (0(5*(1&<86($87+25,=$7,21 (8$ 2) 7+(-$166(1 &29,' 9$&&,1( 7235(9(17 &2521$9,586 ',6($6( &29,' ,1,1',9,'8$/6 <($56 2)$*( $1' 2/'(5
Janssen
Show more
See More
Mar 15, 2022 . By reporting side effects you can help provide more information on the safety of this medicine. Additional note for medicines with a black triangle: This medicinal product is subject to additional monitoring and it is therefore important to report any suspected adverse events related to this medicinal product.
Show more
See More
Janssen COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers - 简体中文 (Chinese, Simplified (Mandarin dialect)) PDF Food and Drug Administration Learn More About COVID-19 Vaccines From the FDA - English HTML
Show more
See More
Pharmaceutical Companies of Johnson & Johnson, please visit Janssen.com If you have product-related questions, please contact a specialist: US Toll Free: 1-800-565-40081-800-565-4008 US Toll: 1-908-455-99221-908-455-9922 © Janssen Therapeutics, Division of Janssen Products, LP 2021. All rights reserved. 12/21 cp-201876v20.
The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older. Emergency Use Authorization Status: Authorized
Johnson & Johnson and Janssen Pharmaceuticals are committed to identifying and mitigating the risks of counterfeit healthcare products. Information regarding how we address counterfeiting can be found at healthforhumanityreport.jnj.com